The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

By R. Kim, E. Wu, Allen Rafael, Enn‐ling Chen, M. Parker, O. Simonetti, F. Klocke, R. Bonow, R. Judd. New England Journal of Medicine, 2000

3,328 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review (2016, background): “Late gadolinium enhancement Late Gadolinium Enhancement (LGE) has become the reference standard for non-invasive imaging of myocardial scar and focal fibrosis in both ischaemic [3] and nonischaemic cardiomyopathy [4].”
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. (2017, result): “LGE-CMR imaging has a high diagnostic accuracy for assessing the transmural extent of myocardial scar tissue.(288) However, the ability to detect viability and predict recovery of wall motion is not significantly superior to other imaging techniques.”
Assessment of Myocardial Fibrosis with Cardiac Magnetic Resonance (2011, background): “In ischemic cardiomyopathy, the transmural extent of LGE is predictive of myocardial wall recovery after revascularization, but it is also predictive of adverse LV remodeling (46,81).”
Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. (2008, background): “Regional myocardial fibrosis due to ischemic heart disease is well described with delayed contrast enhancement sequences on cardiac magnetic resonance imaging (CMRI) ( 14 ,15).”